aTyr Pharma's total assets for Q4 2024 were $96.83M, an increase of 5.69% from the previous quarter. ATYR total liabilities were $27.00M for the fiscal quarter, a 1.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.